Suppr超能文献

舒林酸。一种新型抗炎药物的试验。

Sulindac. Trials of a new anti-inflammatory drug.

作者信息

Huskisson E C, Scott J

出版信息

Ann Rheum Dis. 1978 Feb;37(1):89-92. doi: 10.1136/ard.37.1.89.

Abstract

Trials in patients with rheumatoid arthritis and osteoarthritis showed sulindac to be an analgesic with anti-inflammatory properties and at least as effective as aspirin. It was effective within 24 hours in doses of 300-400 mg daily. It had the advantages of twice daily administration and a lower incidence of gastric side effects than aspirin. Constipation, usually mild, occurred in 20-30% of cases. Like other anti-inflammatory drugs, it was effective in only a proportion of the patients.

摘要

针对类风湿性关节炎和骨关节炎患者的试验表明,舒林酸是一种具有抗炎特性的镇痛药,其疗效至少与阿司匹林相当。每日剂量为300 - 400毫克时,24小时内即可起效。它具有每日给药两次的优点,且胃部副作用的发生率低于阿司匹林。便秘通常较轻,在20% - 30%的病例中出现。与其他抗炎药一样,它仅对一部分患者有效。

相似文献

2
Comparison of sulindac and aspirin in rheumatoid arthritis.
Curr Med Res Opin. 1977;4(7):485-91. doi: 10.1185/03007997709109337.
3
[Treatment of chronic polyarthritis with Sulindac].
MMW Munch Med Wochenschr. 1977 Oct 21;119(42):1369-70.
5
Clinical trials of Sulindac in rheumatoid and osteoarthritis.
Acta Rhumatol Belg. 1977 Jul-Dec;1(3-4):257-61.
8
Sulindac: a review of its pharmacological properties and therapeutic efficacy in rheumatic diseases.
Drugs. 1978 Aug;16(2):97-114. doi: 10.2165/00003495-197816020-00001.
10
A multicenter trial of sulindac in osteoarthritis of the hip.
Clin Pharmacol Ther. 1977 Sep;22(3):358-63. doi: 10.1002/cpt1977223358.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验